Search Results 1071-1080 of 18379 for Immunode

1. IL-33 Production by Nasal Epithelial Cells - Mayo Clinic

   We will also exclude volunteers who have been diagnosed with an immunodeficiency disease or cystic fibrosis. Participating Mayo Clinic locations. Study ...

2. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Positive hepatitis C antibody, hepatitis B virus surface antigen, or human immunodeficiency virus test, at screening. History of QT prolongation associated ...

3. Autoimmune hepatitis - Symptoms and causes - Mayo Clinic

   This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

4. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   Known to be human immunodeficiency virus positive; Any clinically significant acute or active bleeding (eg, gastrointestinal, central nervous system); Known ...

5. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

   Known to be human immunodeficiency virus positive; Any clinically significant acute or active bleeding (eg, gastrointestinal, central nervous system); Known ...

6. Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects - Mayo Clinic

   deficiency, human immunodeficiency virus (HIV). - Any history of clinically significant chronic liver disease including esophageal varices, ascites, hepatic ...

7. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) - Mayo Clinic

   Human immunodeficiency virus, hepatitis B virus, or hepatitis C virus positivity. History of solid organ transplantation; Known or suspected allergy or ...

8. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

   risk for bleeding complications from IT injections or biopsies. - Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy (in doses

9. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

   Known seropositive for or active viral infection with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV); Known sensitivity ...

10. A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms - Mayo Clinic

    Concomitant use of combined P-gp and strong CYP3A4 inhibitors e.g. human immunodeficiency virus protease inhibitors, systemically used azole antimycotic ...